Trypanosoma cruzi is the causative agent of chronic chagasic cardiomyopathy. Why macrophages (ms), the early responders to infection, fail to achieve parasite clearance is not known. Mouse (RAW 264.7) and human (THP-1 and primary) ms were infected for 3 h and 18 h with T. cruzi TcI isolates, SylvioX10/4 (SYL, virulent) and TCC (nonpathogenic), which represent m stimulation and infection states, respectively. Ms incubated with lipopolysaccharide and gamma interferon (LPS/IFN-␥) and with interleukin-4 (IL-4) were used as controls. We monitored the cytokine profile (using enzyme-linked immunosorbent assay [ELISA]), reactive oxygen species (ROS; fluorescent probes), nitric oxide (·NO; Griess assay), and metabolic state using a customdesigned mitoxosome array and Seahorse XF24 Analyzer. LPS/IFN-␥ treatment of ms elicited a potent increase in production of tumor necrosis alpha (TNF-␣) at 3 h and of ROS and ·NO by 18 h. Upon SYL infection, murine ms elicited an inflammatory cytokine profile (TNF-␣ > > TGF-␤ ؉ IL-10) and low levels of ·NO and ROS production. LPS/IFN-␥ treatment resulted in the inhibition of oxidative metabolism at the gene expression and functional levels and a switch to the glycolytic pathway in ms, while IL-4-treated ms utilized oxidative metabolism to meet energy demands. SYL infection resulted in an intermediate functional metabolic state with increased mitoxosome gene expression and glycolysis, and IFN-␥ addition shut down the oxidative metabolism in SYL-infected ms. Further, TCC-and SYL-stimulated ms exhibited similar levels of cell proliferation and production of TNF-␣ and ROS, while TCC-stimulated ms exhibited up to 2-fold-higher levels of oxidative metabolism and ·NO production than SYL-infected ms. Inhibiting ATP-coupled O 2 consumption suppressed the ·NO generation in SYL-infected ms. Mitochondrial oxygen consumption constitutes a mechanism for stimulating ·NO production in ms during T. cruzi infection. Enhancing the oxidative metabolism provides an opportunity for increased ·NO production and pathogen clearance by ms to limit disease progression.
C
hagas cardiomyopathy is a neglected debilitating disease caused by the blood-borne parasite Trypanosoma cruzi. T. cruzi isolates are classified within six genetic groups (TcI to TcVI) which give insight into the evolution of the parasite (1) . The virulent T. cruzi strain SylvioX10/4 (SYL) (2) and the nonpathogenic T. cruzi isolate (TCC) (3) are both of the TcI lineage which is considered to be the most common cause of disease in the Southern zone countries of South America, Central America, and Mexico. In mice and rats, SYL elicits acute parasitemia and persistent inflammatory infiltrate and injury in the myocardium and skeletal muscle during the chronic disease phase (4) , while infection with the TCC isolate results in no detectable parasitemia or tissue injury (5) .
Macrophages (ms) serve as the first responders to T. cruzi infection, and their inflammatory activation exerts cytotoxic effects via NADPH oxidase (NOX)-mediated superoxide (O 2 · Ϫ ) and inducible nitric oxide synthase (iNOS)-mediated nitric oxide (·NO) production. In the context of T. cruzi, it is suggested that m-derived peroxynitrite, a strong cytotoxic agent, formed by the reaction of ·NO with O 2 · Ϫ , plays a major role in the direct killing of T. cruzi (6) . CD4 ϩ and CD8 ϩ T cells producing type 1 cytokines and CD8
ϩ T cell-mediated cytolytic activity were shown to be activated in response to T. cruzi infection in both experimental models and human patients (reviewed in reference 7); however, infected hosts are unable to clear the parasite and eventually develop chronic chagasic cardiomyopathy and heart failure (8) . Further, rodent models of acute Chagas disease have shown that ms have a dual role in controlling parasitemia and facilitating T. cruzi dissemination to peripheral tissues (9, 10) . These studies suggest that a subpar activation of ms or other innate immune cells may be key to parasite persistence and resultant evolution of chronic disease; however, why ms lack potent anti-parasite cytotoxic responses is not known.
Recent studies have suggested that the metabolic status of ms may govern their functional capabilities (11) . The signature of the proinflammatory ms is the production of high levels of ·NO and tumor necrosis alpha (TNF-␣) associated with the use of glycolysis to meet energy demands (12) . On the other end of the m activation spectrum, immunomodulatory ms primarily depend on the electron transport chain (ETC) and oxidative phosphorylation (OXPHOS) systems for the generation of energy (13) . Evaluating the metabolic response of ms would give insight into their functional status upon T. cruzi stimulation.
In this study, we investigated how ms activate to an insufficient inflammatory phenotype in response to T. cruzi infection.
Nitric oxide (·NO) and reactive oxygen species (ROS) detection. The ·NO level in culture supernatants was measured by assaying the concentrations of nitrite (a stable nitric oxide breakdown product) in the culture supernatants by using the Griess assay (14) . Briefly, 50 l of supernatant samples was incubated for 5 min with 50 l of 1% sulfanilamide made using 5% phosphoric acid and then with 50 l of 0.1% N-(1-napthyl) ethylenediamine dihydrochloride (Sigma-Aldrich). Formation of diazonium salt was monitored at 545 nm (standard curve, 0 to 50 M sodium nitrite). To measure ROS release, 50 l of culture supernatants was incubated for 5 min with final reaction concentrations of 33 M Amplex Red reagent (Thermo Scientific, Waltham, MA) and 0.1 U/ml horseradish peroxidase (final volume, 150 l). The oxidation of Amplex Red to fluorescent resorufin by H 2 O 2 (excitation wavelength, 563 nm [Ex 563 ]; emission wavelength, 587 nm [Em 587 ]) was recorded on a SpectraMax M5 microplate reader (standard curve, 0 to 10 M H 2 O 2 ) (15) . To evaluate intracellular ROS levels, ms were seeded in black-walled, clear-bottom 96-well plates and infected with T. cruzi isolates for 3 h or 18 h as described under "Parasites and macrophage cultures" above. The cells were washed, replenished with 100 l culture media, and incubated for 30 min in the presence of 50 M 2=,7=-dichlorodihydrofluorescein diacetate (H 2 DCFDA; Molecular Probes, Eugene, OR) at 37°C and 5% CO 2 . The cells were washed twice with phosphate-buffered saline (PBS) and loaded with 100 l PBS, and then the intracellular ROS-dependent formation of 2=,7=-dichlorofluorescein (DCF) was analyzed at Ex 485 /Em 538 by fluorimetry (16) . To monitor the mitochondrial superoxide, RAW 264.7 macrophages were seeded in black-walled, clear-bottom 96-well plates and infected with T. cruzi isolates for 18 h. Cells were washed twice with PBS, incubated for 30 min in the presence of 5 M MitoSox Red (Molecular Probes), and then washed and replenished with 100 l Hanks balanced salt solution (HBSS). MitoSOX Red is rapidly and selectively targeted to the mitochondria, where its oxidation by superoxide results in release of red fluorescence that was measured at Ex 510 / Em 580 by fluorimetry.
Quantitative reverse transcription-PCR (RT-qPCR) for analyzing oxidative metabolism. The custom-designed mitoxosome arrays consisting of primer sets for probing the expression profiles of 45 key genes related to oxidative phosphorylation and mitochondrial biogenesis (plus 1 reference gene) were designed in collaboration with Tom Wood at the Biomolecular Resource Facility at the UTMB Galveston (Table 1) . The oligomers were then synthesized (IDT, Coralville, IA) and validated for the generation of a single product in quantitative PCR (qPCR) under the thermal cycling conditions described below. All primer sequences are available upon request. Total RNA from the cells was extracted by using TRIzol reagent (Sigma-Aldrich) following the manufacturer's instructions. The DNA that might have been contaminating the RNA preparation was removed using an RNA purification kit (Ambion, Austin, TX). The RNA pellets were resuspended in Molecular Grade water (Corning) and then quantified by using a NanoDrop-1000 spectrophotometer (Thermo Scientific, Waltham, MA). The total RNA (500 ng) was reverse transcribed in a 20-l reaction mixture by using an iScript cDNA synthesis kit (Bio-Rad, Hercules, CA). The cDNA was distributed equally across the gene array to be used as a template on a CFX Real-Time PCR detection system (Bio-Rad). The real-time PCR mix (20 l) consisted of cDNA, 10 l SYBR green master mix (Bio-Rad), and a 500 nM concentration of each of the gene-specific oligonucleotides. The thermal cycle conditions were 94°C for a 15-s denaturation step followed by annealing and extension at 60°C for 1 min for 40 cycles. The threshold cycle (C T ) values for target mRNAs were normalized to the C T values for the 16S RNA gene sequence, and then the relative fold change of each target gene expression was calculated as 2
Ϫ⌬⌬CT by normalization to control group values using PrimePCR Analysis software (Bio-Rad). Values below 1.0 were calculated as negative fold change by dividing by Ϫ1 and are represented as downregulated levels of gene expression compared to the expression in notreatment controls (17) . The indices of glycolytic function were monitored by the extracellular acidification rate (ECAR; mpH per minute) based on lactate efflux (19) and were determined simultaneously with the OCR. A line diagram of ECAR measurements is shown in Fig. S1B in the supplemental material. The ECAR at the basal level (ECAR Basal ) and the increase in the ECAR with oligomycin addition (ECAR Oligomycin ) represented the use of glycolysis for energy demand and total glycolytic capacity, respectively. The glycolytic reserve capacity was calculated as the difference between ECAR Basal and ECAR Oligomycin . Adding 2-deoxyglucose (2DG) inhibited all glycolytic function and allowed a measure of the nonglycolytic acidification rate (18) .
Measurement of cell viability. RAW 264.7 ms (2 ϫ 10 4 per well) were seeded in 96-well plates and incubated with T. cruzi isolates for 3 h or 18 h. Cells were washed twice with PBS and incubated for 30 min in the presence of 0.5 mg/ml of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT; from Sigma-Aldrich) in culture media. The reduction of yellow tetrazolium MTT by dehydrogenase enzymes in metabolically active cells results in the formation of purple formazan crystals. Formazan crystals were solubilized in 100 l of dimethyl sulfoxide (DMSO), and the change in absorbance was measured at 590 nm by using a SpectraMax M5 spectrophotometer.
Giemsa staining of T. cruzi-infected macrophages. A total of 2 ϫ 10 4 RAW 264.7 ms were seeded in Nunc Lab-Tek 8-well chamber slides (Thermo Scientific) and then treated with T. cruzi for 18 h. Cells were washed twice with PBS and then fixed with methanol for 5 min. Methanol was aspirated, and cells were air-dried before incubation with Giemsa working stain was performed. Stock Giemsa stain (Acros Organics, Thermo Scientific) was diluted to a 2.5% working stain in 6.7 mM sodium phosphate buffer-0.0025% Triton X-100 (pH 7.2) and then incubated on the cell slides for 45 min. The stained cells were washed with wash buffer, air-dried, and then visualized at 40ϫ on a light microscope (BX53F Olympus, Center Valley, PA). Statistical analysis. All experiments were conducted with at least triplicate observations per treatment, and data are expressed as means Ϯ standard errors of the means (SEM). Data were analyzed by Student's t test, one-way analysis of variance (ANOVA) with Tukey's post hoc test, or two-way ANOVA with Bonferroni post hoc test by using GraphPad Prism 5 software. Statistical significance for gene expression analysis was calculated by using PrimePCR Analysis software (Bio-Rad). Significant differences compared to no-treatment controls or as otherwise stated are annotated as follows: *, P value Ͻ 0.05; **, P value Ͻ 0.01; and ***, P value Ͻ 0.001.
Accession number(s).
Accession numbers for data determined in this work and deposited in GenBank are presented in Table 1 .
RESULTS
ROS production and NO production, but not TNF-␣ production, are suppressed in macrophages infected with T. cruzi. To assess the quality of the m response to pathogenic T. cruzi SylvioX10/4 (SYL), we quantified the secretion of the proinflammatory activation markers TNF-␣, ROS, and ·NO from murine (RAW 264.7) and human (THP-1 and primary) ms. Macrophages were incubated with T. cruzi for 3 h and 18 h to capture the state of parasite-induced m stimulation and infection, respectively, and ms incubated with LPS/IFN-␥ or IL-4 were used as controls. The LPS/IFN-␥-treated murine ms, compared to ms incubated in media alone, exhibited a Ͼ1,000-fold increase in TNF-␣ release within 3 h (Fig. 1A , P Ͻ 0.001 ANOVA-Tukey's ) that was not further increased at 18 h posttreatment (Fig. 1B) . RAW 264.7 ms infected with SYL (versus no treatment) exhibited a rapid and potent increase in TNF-␣ release at 3 h (P Ͻ 0.001 ANOVA-Tukey's ) that was slightly lower than that noted in LPS/ IFN-␥-treated ms. By 18 h, SYL-infected murine ms exhibited levels of TNF-␣ that were similar to or higher than those noted for LPS/IFN-␥-treated ms (Fig. 1B) . In comparison, murine ms incubated with IL-4 exhibited no increase in TNF-␣ release above the background levels ( Fig. 1A and B) . Human (THP-1-and PBMC-derived) ms treated with LPS/IFN-␥ for 18 h also exhib- ited a potent increase in TNF-␣ release above the background level ( Fig. 1C and D , P Ͻ 0.001 ANOVA-Tukey's ). However, human ms exhibited no significant increase in TNF-␣ release in response to SYL infection ( Fig. 1C and D) , like that noted in IL-4-treated ms. No increase was noted in the immunomodulatory cytokines tumor growth factor-␤ and IL-10 in murine ms incubated with SYL for 3 h or 18 h. Together, the results presented in Fig. 1 suggested that a potent activation of TNF-␣ is a key feature of LPS/ IFN-␥ induced ms and that murine (but not human) ms are capable of responding to SYL infection by elicitation of inflammatory cytokine response.
Macrophage production of ·NO and O 2 · Ϫ , known as nitrosative and oxidative stress, respectively, is an important indicator of the cytotoxicity of phagocytes. Our data showed that ·NO and H 2 O 2 release as well as intracellular ROS (DCF fluorescence) levels were not significantly increased above the background levels in murine ms incubated with LPS/IFN-␥, IL-4, or SYL for 3 h ( Fig.  2A to C) . By 18 h postincubation, LPS/IFN-␥ induced 10-fold and 5-fold increases in ·NO release and intracellular ROS, respectively ( Fig. 2D and E, P Ͻ 0.001 ANOVA-Tukey's ), while no significant differences were observed for H 2 O 2 release (Fig. 2F ) compared to that noted in ms incubated with IL-4 or media alone. RAW 264.7 ms infected with SYL for 18 h exhibited low levels of ·NO (Fig.  2D) , a 2-fold increase in H 2 O 2 release (Fig. 2F) , and no increase in intracellular ROS levels (Fig. 2E ) compared to those noted in normal controls. A significant induction of intracellular ROS was also detected in human THP-1 ms that were incubated with LPS/ IFN-␥ (P Ͻ 0.001 ANOVA-Tukey's ) compared to THP-1 ms incubated with IL-4, SYL, or media alone for 18 h (Fig. 2G) . To identify the source of ROS, we stimulated RAW 264.7 ms with LPS/ IFN-␥ in the presence of an NADPH oxidase (NOX2) inhibitor, diphenyleneiodonium (DPI), and then measured the levels of intracellular ROS and mitochondrial ROS using H 2 DCFDA and MitoSOX Red fluorescent probes, respectively. We found that the inhibition of NOX2 by DPI abolished the LPS/IFN-␥-induced intracellular ROS (Fig. 2H) . Basal levels of mitochondrial ROS that were detected in the no-treatment control ms were further decreased by LPS/IFN-␥ induction, and cotreatment with DPI prevented the LPS/IFN-␥ suppression of mitochondrial ROS in murine ms (Fig. 2I) . Together, the results presented in Fig. 2 suggested that murine and human ms respond by the production of ·NO and ROS in the order LPS/IFN-␥ Ͼ Ͼ SYL Ͼ IL-4 ϭ media alone, where ROS release is increased by NADPH oxidase activation.
Mitochondrial gene transcription is induced in T. cruzi-infected macrophages. Cellular metabolic status can serve as a signaling event in the functional activation of ms toward diverse phenotypes (20) . THP-1 ms were incubated for 12 h with LPS/ IFN-␥ or IL-4, or for 18 h with SYL, and we performed RT-qPCR analysis to probe the expression of 45 mitoxosome genes by using a custom-designed array (Table 1 ). All 45 of the genes were differentially expressed by at least Խ1.5Խ-fold change in ms incubated with LPS/IFN-␥, IL-4, or SYL compared to media alone (Fig. 3A) , and the results for 22 of the genes were statistically significant (P Ͻ 0.05).
A total of 27 genes were differentially expressed by at least Խ1.5Խ-fold change (2 upregulated, 25 downregulated) in LPS/IFN- ␥-induced ms (Fig. 3B and C) , where the upregulation of an antioxidant gene (sod2) and downregulation of 9 genes (mt-nd3, mt-nd6, ndufa5, ndufb5, hspc051, cox5b, mt-co3, mt-atp6, and tfam) involved in the electron transport chain, mitochondrial fission, and mitochondrial and nuclear gene transcription were deemed statistically significant in comparison to the no-treatment m group.
In IL-4-treated ms, only 2 genes (atp5c1 and sod2) were downregulated (P Ͻ 0.05) (Fig. 3C ) and 5 genes were upregulated by ՆԽ1.5Խ-fold (Fig. 3B) , but the results were not significantly different from the expression in the untreated ms (Table 1) . In comparison, SYL-infected ms exhibited upregulation of 27 genes, encoding products involved in the electron transport chain, mitochondrial fission and fusion, and a nuclear polymerase (Fig.  3A) , and the results for 19 of the genes were deemed statistically significant ( Fig. 3B and Table 1 ). Only 4 genes were differentially downregulated, but the results did not show statistical significance (Fig. 3C and Table 1 ). These results suggested that LPS/IFN-␥ switched off the mitoxosome at the transcriptional level and that SYL-infected ms enhanced the gene expression profile conducive to oxidative metabolism.
T. cruzi-infected macrophages fail to switch to glycolytic metabolism. To investigate the metabolic status of ms at the functional level in response to SYL, we employed the XF24 Analyzer to examine two major pathways of energy production: oxidative metabolism based on mitochondrial oxygen consumption rate (OCR; see Fig. S1A in the supplemental material) and glycolysis by extracellular acidification rate (ECAR; see Fig. S1B ). The metabolic status of murine ms incubated with LPS/IFN-␥, IL-4, or SYL for 3 h showed no differences in the levels of basal (OCR Basal -OCR Antimycin ) and ATP-linked (OCR Basal -OCR Oligomycin ) OCR, as well as in proton leak (OCR Oligomycin -OCR Antimycin ), in treated (versus untreated) ms at 3 h (Fig. 4A.a and A.b) . However, FCCP induction of mitochondrial maximal respiration capacity (OCR FCCP -OCR Antimycin ) was found to be 60% (P Ͻ 0.001 ANOVA-BF ) and 35% (P Ͻ 0.05 ANOVA-BF ) higher in IL-4-treated and SYL-infected murine ms, respectively, than in LPS/IFN-␥-treated ms. Likewise, IL-4-treated and SYL-infected ms exhibited 7-fold higher levels of mitochondrial respiratory reserve capacity (OCR FCCP -OCR Basal ) (Fig. 4A .a and A.b, P Ͻ 0.01 to 0.001 ANOVA-BF ). Basal use of the glycolytic pathway for energy demand was enhanced by 1.6-fold and 2-fold by LPS/IFN-␥ and SYL, respectively, compared to that noted in IL-4-treated ms (Fig. 4B.a and B .b, all, P Ͻ 0.001 ANOVA-BF ). After the addition of oligomycin (inhibits complex V ATP synthase activity), the maximal ECAR was increased in all m samples, with the least increase in ECAR being induced by IL-4 treatment. Total levels of glycolytic capacity (ECAR Oligomycin -ECAR Basal ) were not statistically different in any of the macrophage samples at 3 h (Fig.  4B) . Altogether, at 3 h postincubation, (i) LPS/IFN-␥ treatment resulted in a reduction of the mitochondrial maximal and reserve respiration capacity and activation of glycolytic metabolism; (ii) IL-4 induced preferential utilization of oxidative metabolism; and (iii) SYL infection resulted in an intermediate metabolic state that presented with no decline in oxidative metabolism combined with the capability of using glycolysis to meet the energy demand in macrophages.
By 18 h, murine ms incubated with IL-4 and LPS/IFN-␥ were completely polarized in their use of mitochondrial oxidative metabolism and glycolysis, respectively, for energy demand (Fig. 4C and D). LPS/IFN-␥-treated ms showed no use of mitochondrial respiration (Fig. 4C.a and C.b) . In comparison, IL-4-treated ms exhibited Ͼ10-fold higher levels of basal, ATP-coupled, maximal, and reserve mitochondrial respiration (Fig. 4C .a and C.b, all P Ͻ 0.001 ANOVA-BF ) that was abolished by antimycin (inhibits ATPcoupled respiration), thus suggesting that the mitochondrial oxidative metabolism was the major pathway used to fulfill energy demand. Further, SYL-infected murine ms (versus LPS/IFN-␥ ms) continued to utilize mitochondrial oxidative metabolism, though basal, ATP coupled, and maximal respiration levels in SYL-infected ms at 18 h were at 45% to 60% of the levels noted in IL-4-treated ms (P Ͻ 0.001 ANOVA-BF ), and their reserve respiratory capacity was completely depleted (Fig. 4C.a and C.b) . A 2-fold decline in OCR mediated by 2-deoxyglucose (2DG; inhibits glycolysis) in IL-4-treated ms suggested that immunomodulatory ms utilize the glycolytic pathway to feed the substrate to tricarboxylic acid (TCA) cycle-linked oxidative metabolism (Fig.  4C.a and C.b) .
ECAR measurements in murine ms incubated for 18 h showed that LPS/IFN-␥ and SYL induced 57 to 61% more utilization of the glycolytic pathway than IL-4 in ms (ECAR Basal ) (P Ͻ 0.001 ANOVA-BF , Fig. 4D .a and D.b). When mitochondrial respiration was inhibited by oligomycin, IL-4-treated and SYL-infected (versus LPS/IFN-␥-treated) ms were capable of increasing glycolysis as a source of energy and showed high levels of glycolytic reserve capacity (Fig. 4D.a IFN-␥ supplementation during T. cruzi infection promotes a metabolic switch in macrophages. We next investigated if providing IFN-␥ as a secondary stimulus would enhance the metabolic shift of ms treated with T. cruzi. Within 3 h, SYL/IFN-␥-treated ms exhibited a 57% decline in basal and ATP-linked respiration (Fig. 5A .a and A.b, P Ͻ 0.001 ANOVA-BF ) and a partial use of glycolysis (Fig. 5B.a and B. b) compared to the results noted in ms treated with only SYL or in no-treatment ms. By 18 h, SYL/IFN-␥-treated ms exhibited a shutdown of basal, ATP-linked, and maximal mitochondrial oxygen consumption (Fig. 5C .a and C.b) and utilized glycolysis at the maximal capacity (Fig. 5D .a and D.b), which was similar to the results noted in LPS/IFN-␥-treated ms ( Fig. 4C and D) . These results suggested that (i) T. cruzi did not irreversibly affect the macrophage's ability to utilize oxidative or glycolytic metabolism and that (ii) IFN-␥ serves as a signal sufficient to deactivate macrophage respiration and enhance glycolysis during T. cruzi infection.
Oxidative metabolism and NO production of macrophages are augmented in response to TCC. The SYL isolate establishes a chronic infection, while the TCC isolate fails to persist in mice. To determine if a metabolic switch to a glycolytic pathway and LPS/ IFN-␥-like activation was a prerequisite for m control of T. cruzi, we challenged the murine ms with the TCC isolate. Giemsa staining showed no major differences in association of TCC and SYL isolates with RAW 264.7 ms at 3 h (data not shown), and by 18 h, SYL trypomastigotes showed entrance into the host cell cytoplasm whereas some of the TCC trypomastigotes remained attached to the surface of ms at this time point (Fig. 6A.a and A.b) .
In terms of oxidative metabolism at 3 h postincubation, the levels of basal, ATP-linked, and maximal O 2 consumption seen with TCC-infected ms were 54%, 59%, and 56% higher, respectively, than those seen with SYL-infected ms (Fig. 6B.a to 0.001 ANOVA-BF ). TCC-infected ms also exhibited a 60% higher level of mitochondrial spare respiratory capacity (OCR FCCP -OCR Basal ) than SYL-infected ms (Fig. 6B.a and B .b, P Ͻ 0.001 ANOVA-BF ). At 18 h (versus 3 h) postinfection (pi), the maximal OCR of TCC-infected murine ms declined by 3-fold (compare Fig. 6B.b with Fig. 6C .b) but remained higher than the OCR of SYL-infected ms (Fig. 6C .a and C.b, P Ͻ 0.01 ANOVA-BF ). However, no differences in the levels of mitochondrial OCR reserve at 18 h (Fig. 6C.b ) or in ECARs (basal utilization of glycolytic pathway and glycolytic reserve) at 3 h and 18 h postincubation were observed in TCC-and SYL-infected ms (see Fig. S2A and B in the supplemental material). These data suggested that TCC-infected At a functional level, incubation for 3 h elicited no increase in the release of ·NO and H 2 O 2 , and intracellular ROS levels in TCCand SYL-infected (versus uninfected) murine ms (Fig. 7A , panels a to c) and m viability were also not affected by TCC or SYL after 3 h of incubation (Fig. 7A.d) . After 18 h, TCC-and SYLinfected (versus no-treatment) murine ms exhibited 4-fold and 2-fold increases in ·NO release (Fig. 7B .a, P Ͻ 0.001 ANOVA-Tukey's ) and 69% and 47% increases in H 2 O 2 release (Fig. 7B.b , P Ͻ 0.05 to 0.01 ANOVA-Tukey's ), respectively, while no significant change in intracellular ROS levels (Fig. 7B.c) was observed. The SYL-infected and TCC-infected ms exhibited 16.5% (P Ͻ 0.05) and 47.5% (P Ͻ 0.01) increases in proliferation (versus untreated controls), respectively, at 18 h postincubation (Fig. 7B.d) . Further, TCCand SYL-infected (versus uninfected) murine ms exhibited a 10-fold increase in TNF-␣ release (Fig. 7C .a ANOVA-Tukey's ) at 18 h postincubation. THP-1 human ms infected with TCC and SYL isolates for 18 h, compared to no-infection controls, also exhibited 14-fold and 21-fold increases in TNF-␣ release, respectively (Fig.  7C .b, P Ͻ 0.001 ANOVA-Tukey's ), although TNF-␣ release from infected THP-1 ms was lower than that observed in LPS/IFN-␥-treated M1 ms (Fig. 1C) . Together, the results presented in Fig. 6 and 7 and in Fig. S2A and B in the supplemental material suggested that TCC-and SYL-infected ms do not differ in their capacity to produce ROS and TNF-␣ but that TCC-infected ms exhibit enhanced O 2 consump- 4 /well) were seeded in XF24 plates and incubated with SYL or TCC isolates of T. cruzi for 3 h (B) and 18 h (C). The OCR was recorded as described for Fig. 4 . Note that the basal, ATP-linked, and maximal respiration levels are augmented in ms challenged with TCC compared to those challenged with the SYL isolate at 3 h (B.a). By 18 h pi, ms challenged with TCC respired at levels similar to those seen with SYL-infected cells but continued to have an enhanced maximum O 2 consumption capacity (C.a). Bar graphs show mean values (Ϯ SEM) of OCR-based parameters at 3 h (B.b) and 18 h (C.b) derived from the mean of four replicates (triplicate readings per sample). Significance was calculated by two-way ANOVA with Bonferroni post hoc test, and data are expressed as results of comparisons to the SYL-infected ms (**, P Ͻ 0.01; ***, P Ͻ 0.001).
tion, mitochondrial oxidative metabolism, and nitrite production compared to the levels noted in SYL-infected ms.
Inhibition of oxygen consumption suppresses the release of ·NO in macrophages. To determine if m O 2 consumption regulates ·NO production and constitutes a mechanism involved in parasite control, we incubated murine ms with SYL in combination with oligomycin (inhibits ATP synthase and suppresses mitochondrial O 2 consumption) or FCCP (uncouples electron transport chain from ATP synthesis and induces maximal O 2 consumption) and measured the ·NO level at 18 h posttreatment. Oligomycin treatment abolished the SYL-induced 2-fold increase in ·NO levels in infected ms (P Ͻ 0.01 ANOVA-Tukey's , Fig. 8A ), while no significant effect of oligomycin was observed on the SYLinduced ROS levels (Fig. 8B) . Likewise, FCCP treatment had no inhibitory effects on SYL-induced ·NO release in infected murine ms (Fig. 8C) . These results suggested that ATP-coupled O 2 consumption may be a mechanism for ·NO generation by ms during T. cruzi infection.
DISCUSSION
In this study, we investigated how levels of m activation differed in response to T. cruzi isolates that had been shown to exhibit different levels of virulence in mice (21) . We showed that infection with the virulent SYL isolate arrested the ms in an intermediate proinflammatory state with enhanced TNF-␣ production, low levels of ROS and ·NO release, and partial utilization of glycolysis and oxidative metabolism at the gene expression and functional levels. Importantly, TCC-infected ms did not differ from SYLinfected ms in their capacity to produce TNF-␣ and ROS; however, the TCC-infected ms exhibited levels of O 2 consumption, oxidative metabolism, and ·NO production that were up to 2-fold higher than those seen with the SYL-infected ms. These results, to the best of our knowledge, provide the first evidence that mitochondrial O 2 consumption constitutes a mechanism for stimulating ·NO production in ms during T. cruzi infection. We postulate that enhancing the respiratory capacity will provide an attractive strategy for increasing ·NO production and pathogen clearance by ms to limit disease progression.
The proinflammatory markers TNF-␣, ROS, and ·NO are indicators of ms that have been activated for innate immune defense (22) . Indeed, murine and human ms incubated with LPS/ IFN-␥ exhibited a Ͼ1,000-fold increase in TNF-␣ production at 3 h (Fig. 1) that was succeeded by a robust (Ͼ10-fold) increase in ·NO, extracellular H 2 O 2 , and intracellular O 2 · Ϫ generation at 18 h (Fig. 2) . Differential levels of activation in human and mouse cells have also been observed by others (23) . Importantly, both human and mouse ms elicited low levels of oxidative (O 2 · Ϫ , H 2 O 2 ) and nitrosative (·NO) stress upon SYL infection (Fig. 2) . Because ROS and NO and their by-products are strong cytotoxic agents that may directly kill the pathogen (24) or influence the cellular function by formation of adducts on DNA, proteins, and lipids (25, 26) , our data suggest that T. cruzi diminishes the oxidative/nitrosative response to ensure its survival in ms. Our finding of inhibition of ROS by DPI (NOX2 inhibitor) and a lack of mitochondrial ROS stimulated by LPS/IFN-␥ (Fig. 2H and I ) and our prior T. cruzi infection studies in splenocytes and human THP-1 ms (27, 28) suggest that NOX2 is the major source of ROS in ms. How SYL diminishes NOX2 activation to control ROS/NO levels remains to be further investigated. Others have suggested that an elaborate antioxidant network comprising peroxiredoxins that scavenge ROS and NO provides a survival advantage to T. cruzi in immune cells (6) . These observations, along with our finding of increased NO production in TCC-infected (versus SYL-infected) ms (Fig. 7) , allow us to propose that intraphagosomal ROS and ·NO survival constitutes at least one key mechanism of the parasite's persistence in the host.
Electron transport chain (ETC)-coupled oxidative phosphorylation (OXPHOS) is the main source of ATP energy in eukaryotic cells. The immunomodulatory ms are long-lived and regulate immune functions such as by clearing immune complexes, suppressing inflammatory responses, and promoting wound healing (13) . Our data showed that IL-4-induced immunomodulatory ms maintained the transcription levels of ETC and OXPHOS complexes, antioxidant responses, and mitochondrial regulatory enzymes and primarily utilized oxidative metabolism to meet the energy demand. The glycolysis product, pyruvate, may be reduced to lactate, resulting in ATP release, or may provide acetyl-coenzyme A (acetyl-CoA) to support the TCA cycle. Our finding of a decline in the oxygen consumption rate (OCR) in IL-4-treated ms after addition of 2-DG (Fig. 4C.a) suggested that these ms utilize the glycolytic pathway to drive pyruvate to feed the TCA cycle and generate reduced (NADH/NADPH) energy for oxidative metabolism (29, 30) . Our data also suggest that the use of oxidative metabolism in IL-4-induced ms was not because of an inability to use glycolysis for producing energy, as shown by a metabolic switch to glycolysis after ATP synthase inhibition (Fig.  4D.a) . The LPS/IFN-␥-induced proinflammatory ms solely utilized the glycolytic pathway for meeting the energy demand and shut down the oxidative metabolism at the transcriptional and functional levels ( Fig. 3 and 4) . How the metabolism is shifted and how it may drive the inflammatory versus immunomodulatory phenotype in ms remain incompletely understood. Some studies have suggested that poly(ADP-ribose) polymerase 1 (PARP1), a DNA repair enzyme activated by ROS-induced DNA adducts, depletes the NAD ϩ substrate required for normal activity of sirtuin 1, a metabolic sensor (31, 32) , and may activate cells to utilize a glycolytic pathway for energy (33) . In our present study, we indeed observed the downregulation of mitoxosome gene expression in m stimulated with LPS/IFN-␥; but we noted early metabolic polarization in ms responding to LPS/IFN-␥ and IL-4 at 3 h (Fig. 4A and B ) before significant increases in ROS and ·NO levels at 18 h (Fig. 2) . This suggests that ROS-induced PARP1 activation would occur after the transcriptional inhibition of mitochondrial oxidative metabolism and may have a role in the maintenance of glycolysis in cells. In the ms responding to SYL, the metabolic and cytotoxic phenotype was arrested at an intermediate state with an LPS/IFN-␥-like activation of glycolysis with TNF-␣ production and IL-4-like oxidative metabolism at the gene expression and functional levels and low levels of ROS and NO production. The addition of IFN-␥ lifted the T. cruzi-induced metabolic block, which suggests that IFN-␥ secreted by nearby cells in an in vivo disease system could aid in the proinflammatory metabolic activation of macrophages for T. cruzi killing. How IFN-␥ regulates the metabolic state of the ms remains to be investigated in future studies.
Secreted factors originating from T. cruzi influence the host cell signaling pathways for successful infection (reviewed in reference 34). One of these soluble proteins, cruzipain, has been found to enhance arginase activity (35) , which is a key characteristic in immunomodulatory/IL-4-polarized murine ms. Trypanosoma phospholipase A1 is a virulence factor that has been shown to generate secondary lipid messengers and to activate protein kinase C (36), an enzyme that promotes glycolysis in B cells (37) in host cells. These T. cruzi molecules may prove to be significant in reducing T. cruzi pathogenesis or improving the m response by affecting the metabolic processes.
TCC is a low-pathogenicity T. cruzi strain that has been previously studied for its immunogenicity (38) and was recently found to be controlled by ms (39) . Surprisingly, TCC-treated ms, instead of switching to a glycolytic pathway for energy demand, consumed more oxygen and exhibited heightened oxidative metabolism at 3 h pi and then produced higher levels of ·NO than SYL-infected ms. These results suggest that ·NO may contribute to T. cruzi killing as multiple reactive nitrogen species (RNS) (40) . High oxygen consumption has been described to correlate with increased ROS levels in neutrophils and PBMCs activated with diverse stimuli (41, 42) and with L-arginine supplementation for endothelial NOS activity (43) . Yet, with T. cruzi infection of ms, we did not observe potent ROS generation but instead observed augmented ·NO production in response to the TCC isolate. Arginase 1 (Arg1) competes with iNOS for arginine for the synthesis of ornithine and polyamines, which results in a net effect of reduced production of RNS (44) . Thus, one possibility is that increased O 2 consumption diverts the arginine metabolism from Arg1 to ·NO production in TCC-infected ms; however, the mere increase in O 2 consumption caused by FCCP treatment of the SYL-infected ms did not further increase ·NO production (Fig. 8) . Instead, inhibiting ATP synthase and OXPHOS with oligomycin caused a significant decline in ·NO release in infected ms (Fig. 8) . These data suggest that O 2 consumption-linked ATP synthesis is important for the generation of ·NO by ms in response to T. cruzi. Our observation of a direct relationship between OXPHOS and ·NO in T. cruzi-infected ms differs from the literature wherein others have documented the ·NO as being an antagonist for O 2 consumption (45, 46) . The kinetics of O 2 consumption and ·NO production in T. cruzi-infected ms will provide further insight into how phagocytes may achieve parasite clearance while preventing overactivation of mitochondrial function and ·NO to ensure host survival.
Antigenic lysates of intracellular pathogens have the potential to activate the inflammatory profile of immune cells. In the context of T. cruzi, prepared lysates are insufficient to activate an inflammatory response in ms and splenocytes. Human THP-1 ms were shown to lack induction of IL-1␤ with either live T. cruzi and T. cruzi lysate stimulation compared to LPS treatment (28) . Splenocytes isolated from normal mice respond to T. cruzi lysates with low levels of production of H 2 O 2 that were enhanced only when splenic cells were primed with live T. cruzi before secondary stimulation with T. cruzi lysate (27) . Further, expression of the proinflammatory cytokines IL-1␤, IL-6, TNF-1␣, and IFN-␥ and the immunomodulatory cytokine IL-4 was not elicited by T. cruzi lysate treatment compared to no-treatment controls (27) . Others have shown that inoculation with heat-killed T. cruzi induced cardiac damage but lacked inflammatory qualities in the heart and splenocytes compared to the results seen with T. cruzi-infected mice (47) . These observations suggest that immune cells do not respond to heat-killed T. cruzi or T. cruzi lysates with an enhanced proinflammatory profile compared to live T. cruzi.
In summary, we have investigated the antimicrobial and metabolic responses of ms to T. cruzi. Our results suggested that ·NO and oxidative metabolism, rather than complete activation of inflammatory phenotypes like those seen with LPS/IFN-␥-treated ms, may be the key components for the resistance and cytotoxic response of macrophages to T. cruzi. To our knowledge, this is the first report that ·NO formation can be dependent on mitochondrion-linked oxygen consumption in ms and that mitochondrial respiration can be beneficial in an antimicrobial response by ms.
